Financial News

Where Is Mentor Capital Inc (OTCMKTS:MNTR) Heading?

In its last quarterly report, Mentor Capital Inc (OTCMKTS:MNTR) stated that revenue for the quarter closed June 2016 was $667,720 versus $628,386 for the...

Newgen Concepts Inc (OTCMKTS:VPOR) Announces First Production Run Of Easy Grinder™ Sold Out

Newgen Concepts Inc (OTCMKTS:VPOR) announced that its preliminary production run of Easy Grinder™ planned to manufacture 20,000 units, which will generate gross revenue of...

Airborne Wireless Network (OTCMKTS:ABWN) Updates On Trading Activity

A couple of days earlier, Airborne Wireless Network (OTCMKTS:ABWN), a Nevada corporation was made alert of and requested by the OTC marketplace, to comment...

Why Is TG Therapeutics Inc (NASDAQ:TGTX) In Focus?

TG Therapeutics Inc (NASDAQ:TGTX) stock has been in utmost focus in the last few trading session. The major reason behind this growing interest in...

Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Seeking Nod To Supply NurOwn® In Canada

Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) has signed a deal with CCRM, a Toronto-based pioneer in commercializing and developing regenerative medicine technologies, and gene and...

Internap Corp (NASDAQ:INAP) Updates On Common Equity Private Placement

Internap Corp (NASDAQ:INAP) reported a private placement of almost 23.8 million shares at a price of $1.81 per share, for gross proceeds of almost...

SPYR Inc (OTCMKTS:SPYR) Pulls Back Amid Major New Positive Catalysts

SPYR Inc (OTCMKTS:SPYR) is a micro-cap player we have been pointing to for some time. The company is an emerging leader in mobile gaming,...
Bellerophon Therapeutics Inc

Bellerophon Therapeutics Inc (NASDAQ:BLPH) Reports FDA Approvals Of Changes to INOpulse Pulmonary Arterial Hypertension...

Bellerophon Therapeutics Inc (NASDAQ:BLPH) has acquired nod from the U.S. FDA of the Agency’s support of all modifications suggested by the firm to its...

Barclays Neutral On Community Health Systems (NYSE:CYH)

Community Health Systems (NYSE:CYH) released its fourth quarter report, which came positive and indicate an end to its worsening financials. This statement was released...

Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) And Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Enter Into Licensing Deal...

Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) have entered into a worldwide licensing deal through which EyeGate has provided a subsidiary...

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: https://www.journaltranscript.com/disclaimer

Get Our FREE e-Alerts on the Market’s Latest Trends in Cannabis, Energy, Health Care, Metals, and Technology.

Get Our FREE e-Alerts on the Market’s Latest Trends in Cannabis, Energy, Health Care, Metals, and Technology.